Thus, the iKras* p53* mouse model recapitulates the histology and biological behavior of human pancreatic cancer and previous mouse models with the additional ability to control Kras* expression in a time and organ-selective manner. This evidence concerns the gene TP53 and pancreatic neoplasm.